Evolving concepts and translational relevance of enteroendocrine cell biology

Journal of Clinical Endocrinology and Metabolism

Volumn 101, Issue 3, 2016, Pages 778-786

  Drucker, Daniel J ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; GASTRIC INHIBITORY POLYPEPTIDE; GASTRIN; GASTROINTESTINAL HORMONE; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; GLUCAGON LIKE PEPTIDE 2; NUCLEAR FACTOR Y; PEPTIDE YY; PREBIOTIC AGENT; PROBIOTIC AGENT;

ARTICLE; BARIATRIC SURGERY; CARCINOGENESIS; CELL FUNCTION; CELL MEMBRANE POTENTIAL; ENDOCRINE TUMOR; ENTEROENDOCRINE CELL; ENTEROENDOCRINE CELL TUMOR; GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR; HOMEOSTASIS; HORMONAL REGULATION; HORMONE ACTION; HUMAN; INTESTINE FLORA; METABOLOME; MOLECULAR MODEL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PLEIOTROPY; PRIORITY JOURNAL; TRANSCRIPTOMICS; INTESTINAL NEOPLASMS; NEUROENDOCRINE TUMORS; NOMENCLATURE; PHYSIOLOGY; SECRETION (PROCESS);

ENTEROENDOCRINE CELLS; GLUCAGON-LIKE PEPTIDE 1; HOMEOSTASIS; HUMANS; INTESTINAL NEOPLASMS; NEUROENDOCRINE TUMORS; TERMINOLOGY AS TOPIC;

EID: 84960876649     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-3449     Document Type: Article

References (25)

1. Wang J, Cortina G, Wu SV, et al. Mutant neurogenin-3incongenital malabsorptive diarrhea. N Engl J Med. 2006;355:270-280.
2. Habib AM, Richards P, Cairns LS, Rogers, et al. Overlap of endocrine hormone expression in the mouse intestine revealed by tran-scriptional profiling and flow cytometry. Endocrinology. 2012;153: 3054-3065.
3. Egerod KL, Engelstoft MS, Grunddal KV, et al. A major lineage of enteroendocrine cells coexpress CCK, secretin, GIP, GLP-1, PYY, and neurotensin but not somatostatin. Endocrinology. 2012;153: 5782-5795.
4. Grün D, Lyubimova A, Kester L, et al. Single-cell messenger RNA sequencing reveals rare intestinal cell types. Nature. 2015; 525(7568):251-255.
5. Campbell JE, Drucker DJ. Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metab. 2013;17:819-837.
6. Mulvihill EE, Drucker DJ. Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors. Endocr Rev. 2014;35(6):992-1019.
7. Amcheslavsky A, Song W, Li Q, et al. Enteroendocrine cells support intestinal stem-cell-mediated homeostasis in Drosophila. Cell Rep. 2014;9:32-39.
8. Scopelliti, A, Cordero JB, Diao F, et al. Local control of intestinal stem cell homeostasis by enteroendocrine cells in the adult Drosoph-ila midgut. Curr Biol. 2014;24:1199-1211.
9. Drucker DJ, Yusta B. Physiology and pharmacologyofthe enteroen-docrine hormone glucagon-like peptide-2. Annu Rev Physiol. 2014; 76:561-583.
10. Spence JR, Mayhew CN, Rankin SA, et al. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature. 2011;470:105-109.
11. Watson CL, Mahe MM, MúneraJ, et al. Aninvivo modelofhuman small intestine using pluripotent stem cells. Nat Med. 2014;20: 1310-1314.
12. Petersen N, Reimann F, Bartfeld S, et al. Generation of L cells in mouse and human small intestine organoids. Diabetes. 2014;63: 410-420.
13. Sinagoga KL, Wells JM. Generating human intestinal tissues from pluripotent stem cells to study development and disease. EMBO J. 2015;34:1149-1163.
14. Psichas A, Reimann F, Gribble FM. Gut chemosensing mechanisms. J Clin Invest. 2015;125:908-917.
15. Bohórquez DV, Shahid RA, Erdmann A, et al. Neuroepithelial cir cuit formed by innervation of sensory enteroendocrine cells. J Clin Invest. 2015;125:782-786.
16. Ellingsgaard H, Hauselmann I, Schuler B, et al. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med. 2011;17:1481-1489.
17. Yusta B, Baggio LL, Koehler J, et al. GLP-1R agonists modulate enteric immune responses through the intestinal intraepithelial lymphocyte GLP-1R. Diabetes. 2015;64:2537-2549.
18. Wichmann A, Allahyar A, Greiner TU, et al. Microbial modulation of energy availability in the colon regulates intestinal transit. Cell Host Microbe. 2013;14:582-590.
19. Cani PD, Possemiers S, Van de Wiele T, et al. Changes in gut mi-crobiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut. 2009;58:1091-1103.
20. Yano JM, Yu K, Donaldson GP, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015;161: 264-276.
21. Finan B, Ma T, Ottaway N, et al. Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans. Sci Transl Med. 2013;5:209ra151.
22. Finan B, Yang B, Ottaway N, et al. Arationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents. Nat Med. 2015;21:27-36.
23. Sadry SA, Drucker DJ. Emerging combinatorial hormone therapies for the treatment of obesity and T2DM. Nat Rev Endocrinol. 2013; 9:425-433.
24. Kunz PL. Carcinoid and neuroendocrine tumors: Building on success. J Clin Oncol. 2015;33:1855-1863.
25. Banck MS, Kanwar R, Kulkarni AA, et al. The genomic landscape of small intestine neuroendocrine tumors. J Clin Invest. 2013;123: 2502-2508.